Several studies (17, 18) have assessed insulin resistance using the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) and found that DM1 patients exhibit elevated fasting plasma insulin levels (i.e., hyperinsulinemia) and significantly higher HOMA-IR scores compared to healthy controls. The gene discussed is INS; the disease is hyperinsulinism.